Taj Pharma India Ltd. is a vertically integrated generic pharmaceutical manufacturer with a global footprint across more than fifty countries. We specialise in finished dosage formulations across solid orals, dispersibles, injectables and topicals - with a deep portfolio in oncology supportive care, anti-infectives, hematology and rare disease therapy.
Manufacturing Facility - Sarigam, Gujarat #
Our flagship oral solids facility is located in Sarigam GIDC, Gujarat. The plant is purpose-built to current WHO-GMP standards and operates with segregated suites for general orals and high-potency products such as Deferasirox. Process equipment is qualified per IQ/OQ/PQ protocols, and every batch is released only after full physical, chemical and microbiological verification by Quality Control under independent Quality Assurance oversight.
Certifications #
- WHO-GMP - Good Manufacturing Practice certification.
- ISO 9001:2015 - quality management system.
- PIC/S aligned - processes designed in line with the Pharmaceutical Inspection Co-operation Scheme.
- ICH Q1A(R2) stability programme covering long-term, intermediate and accelerated conditions.
Global Presence #
We export to regulated and emerging markets across LATAM, Africa, Asia and CIS. Our regulatory affairs team supports product registration through Module 1-5 CTD dossiers, country-specific labelling, and post-approval variations. Distributors and tender agents in over fifty countries rely on Taj Pharma for predictable supply, technical support and competitive economics.
Batch Consistency & Regulatory Success #
Our process validation strategy follows a lifecycle approach - from design qualification through continued process verification - ensuring every batch of DEFRATAJ meets predetermined critical quality attributes. Year-on-year audit success with national regulators across our markets reflects our commitment to data integrity, ALCOA+ principles and continuous improvement.